April 10–12, 2026 – The 23rd Mevos Research Conference was grandly held in Hangzhou. Marking the 11th anniversary of Singfiller, Singclean Medical, guided by the philosophy of "precision filling," launched two new products – Singfiller (0.75mL×2) and Singfiller PRO (1.1mL). With a differentiated product portfolio and continuously upgraded service systems, Singclean Medical is joining the industry in opening a new decade of medical aesthetics.

11 Years of Excellence: The Singfiller Legacy

Since obtaining its domestic medical device registration certificate in 2015, becoming one of the first brands in China to receive approval for cross-linked hyaluronic acid used in plastic surgery, Singfiller has expanded to over 30 countries and regions worldwide over the past 11 years. Registered in the EU, the Middle East, and Southeast Asia, Singfiller is now used in more than 7,000 hospitals and aesthetic clinics globally. At every step, Singfiller has strived to stay at the forefront of the industry.

At this year's Mevos conference, Singclean Medical unveiled two major new products, focusing on differentiated injection scenarios to truly solve the industry pain point of "using one hyaluronic acid for the entire face."

Two New Launches: Precision Coverage for Diverse Injection Scenarios

Singfiller PRO (1.1mL) | Flagship for Bony Support

After its global debut at AMWC in Monaco, Singfiller PRO made a remarkable appearance at Mevos 2026, paying tribute to the 11th anniversary of Singfiller. Featuring a macro-molecular design, it achieves three major breakthroughs: extra-large particle size, extra-large volume, and extra-strong support. It is ideal for facial bony support and deep contour shaping.

Singfiller (0.75mL×2) | Specialized for Fine Filling

This medium-molecular formula is specially designed for fine filling. It offers balanced flexibility and firmness, enabling natural contouring. Its ideal viscoelasticity provides a more controllable shaping effect, allowing for precise refinement and natural, lively expressions.

The precision filling philosophy embodied by these two products covers a wide range of injection scenarios – from fine detailing to bony support – and has received high recognition from experts, distributors, and aesthetic practitioners at the conference.

Academic Highlight: From Facial Contouring to Gluteal Augmentation Practice Overseas

On April 11, Dr. Zhong Xi, founder of the "Aesthetic Solution Hub" platform, delivered a keynote speech titled "Singfiller PRO: From Facial Contouring Benchmark to Overseas Gluteal Augmentation Clinical Practice." The presentation sparked enthusiastic discussion and drew continuous applause.

Dr. Zhong pointed out that the market has long lacked a safe, effective hyaluronic acid product suitable for body contouring. He emphasized that HA for gluteal injections requires extremely high viscoelasticity to ensure gel integrity and volume stability, thereby minimizing migration and deformation over time.

As an extension of its contouring strength, Singfiller PRO (1.1mL) delivers comprehensive upgrades in key parameters such as particle size, viscosity, and elasticity. With advanced crosslinking and purification technologies, BDDE crosslinker is undetectable, and durability is extended. Dr. Zhong noted that the customizable characteristics of Singfiller PRO can meet diverse scenario needs and are expected to bring Chinese consumers a more adaptable and differentiated injection experience.

Looking Ahead: Platform-based R&D, Shaping the Future of Aesthetic Medicine

Moving forward, Singclean Medical will continue to leverage its platform-based R&D advantages and pursue a path of differentiated innovation. By collaborating with global partners and clinical physicians – empowering technology through academia and building trust through service – Singclean aims to provide safe, effective "Chinese solutions" and co-create a new direction for medical aesthetics.

From precise facial filling to body contouring, the Singfiller brand is demonstrating the strength of Chinese medical aesthetic innovation through solid clinical data and expanding applications. At Mevos 2026, Singclean Medical delivered an outstanding performance with its two new products, writing a confident opening chapter for the next decade.